NCT02994771 2023-04-24A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary LymphedemaHerantis Pharma Plc.Phase 1 Terminated15 enrolled
NCT04073823 2023-01-18A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema PatientsTactile MedicalPhase NA Terminated2 enrolled 15 charts